Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial

BACKGROUND: Inhaled corticosteroids (ICS) are frequently prescribed outside guidelines to patients with chronic obstructive pulmonary disease (COPD) with mild/moderate airflow limitation and low exacerbation risk. This primary care trial explored the feasibility of identifying patients with mild/mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Harries, Timothy H, Gilworth, Gill, Corrigan, Christopher J, Murphy, Patrick, Hart, Nicholas, Thomas, Mike, White, Patrick T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438092/
https://www.ncbi.nlm.nih.gov/pubmed/36041773
http://dx.doi.org/10.1136/bmjresp-2022-001311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438092/
https://www.ncbi.nlm.nih.gov/pubmed/36041773
http://dx.doi.org/10.1136/bmjresp-2022-001311

Ejemplares similares